The Generative Brain
CeGaT GmbH logo

CeGaT GmbH

CeGaT GmbH is a privately held genetic testing laboratory founded in 2009 in Tuebingen, Germany, run by its founders Saskia and Dirk Biskup and fully founder owned again since April 2024, when B. Braun sold back the stake it had held since 2012. It holds DAkkS ISO 15189 and ISO 17025 accreditation plus CAP and CLIA, with several US state licences. For prion disease it lists a PRNP single gene test by Sanger sequencing, PRNP within the NGS Dementia panel NDD17, PRNP in a 9 gene predictive dementia panel that requires genetic counselling, and segregation testing for known family variants. Prices are not published and detection of octapeptide repeat insertions is not stated. Information only.

Key facts

  • Legal entity CeGaT GmbH at Paul-Ehrlich-Str. 23, 72076 Tuebingen, registered at Amtsgericht Stuttgart as HRB 729958; managing directors Dr. Dirk Biskup and Dr. Dr. Saskia Biskup as of 2026-10-16.
  • Founded in 2009 by human geneticist Saskia Biskup and business economist Dirk Biskup; about 200 staff stated; two divisions, Genetic Diagnostics and Research and Pharma Solutions.
  • B. Braun took a 20 percent stake in early 2012 and sold its shares back to the founders as of 1 April 2024, leaving the company fully founder owned; a building extension tripling space opened in April 2024.
  • Accreditation: DAkkS D-PL-13206-01-00 to ISO 15189 and ISO/IEC 17025, CAP 8848535, CLIA 99D2130225, and Rhode Island, Maryland, Pennsylvania and California licences; GTR shows the ISO 15189 number as D-ML-13206-01-00.
  • GTR000524293 is a clinical PRNP single gene test by bi-directional Sanger sequencing of the whole coding region, for inherited CJD, fatal familial insomnia, GSS and related conditions, done fully in house; the lab director listed is Saskia Biskup.
  • Single gene work uses Sanger sequencing with MLPA or qPCR for deletions and duplications in over 350 genes, turnaround typically under 4 weeks, on EDTA blood, DNA, dried blood spot, buccal swab or saliva; a separate segregation form covers testing relatives for a known variant.
  • The Dementia panel NDD17 lists 22 genes including PRNP plus APOE genotyping, with C9ORF72 repeat analysis first, by hybridisation capture and Illumina sequencing with CNV calling and a 3 to 4 week turnaround; GTR000522519 instead lists 36 analytes.
  • A predictive dementia panel for healthy people covers 9 genes including PRNP and makes counselling with a human genetics specialist, then consent, an absolute prerequisite; individuals may contact the lab directly and counselling can be by video.
  • Ordering is by paper form or the myCeGaT portal, and a free diagnostic support team advises physicians; the contact form accepts inquiries from physicians, patients, relatives and researchers with a country of residence list.
  • No prices, price list or international billing terms appear on the home, panel, single gene, predictive, support or downloads pages.
  • In NCBI GTR, CeGaT is one of several labs listing PRNP tests, with Labcorp Genetics, Fulgent, Blueprint Genetics and DNA Labs India.
  • No India office, partner or distributor was found on CeGaT pages or in a web search.

Timeline

  1. 2009CeGaT founded in Tuebingen by Saskia and Dirk Biskup.
  2. 2011Company receives the German Founder Prize.
  3. 2012B. Braun announces a 20 percent stake in CeGaT.
  4. 2018CeGaT announces its California clinical laboratory licence, adding to federal CLIA certification.
  5. 2024B. Braun shares return to the founders; company fully founder owned.
  6. 202415th anniversary and opening of the building extension.
  7. 2025California licence document updated on the accreditation page.
  8. 2025Reported expansion to four NovaSeq X Plus sequencers (search excerpt only).
  9. 2026Older dementia panel URL returns not found; current panel sits under neurodegenerative diseases as NDD17.
Sources for this page